About FDA
Performance at a Glance for FY 2005 and FY 2006 ADUFA FY 2006
The horizontal bar graphs provide FDA actual and preliminary “on-time” performance on actions related to submissions for new Animal Drug Applications (NADAs) and Reactivations, Administrative NADAs and Reactivations, Non-manufacturing Supplemental NADAs and Reactivations, Manufacturing Supplemental NADAs and Reactivations, INAD Study Submissions, and INAD Study Protocol Submissions. All performance goals are at 90 percent of actions. Performance results for FY 2005 and preliminary performance results for FY 2006 show that FDA is exceeding the performance levels that were set for each of these goals.







